Kynurenine Pathway in Schizophrenia: Galantamine-Memantine Combination for Cognitive Impairments.

Authors

Maju Mathew Koola, George Washington UniversityFollow
Jennifer Sklar
Whitney Davis
Agnieszka Nikiforuk
John K Meissen
Aarti Sawant-Basak
Scott T Aaronson
Rouba Kozak

Document Type

Journal Article

Publication Date

7-10-2017

Journal

Schizophrenia Research

DOI

10.1016/j.schres.2017.07.005

APA Citation

Koola, M., Sklar, J., Davis, W., Nikiforuk, A., Meissen, J., Sawant-Basak, A., Aaronson, S., & Kozak, R. (2017). Kynurenine Pathway in Schizophrenia: Galantamine-Memantine Combination for Cognitive Impairments.. Schizophrenia Research, (). http://dx.doi.org/10.1016/j.schres.2017.07.005

Peer Reviewed

1